The Role of Delayed Radiotherapy Initiation in Patients with Newly Diagnosed Glioblastoma with Residual Tumor Mass.
Johannes DietterleClara FrydrychowiczKatja JähneTim WendeFlorian WilhelmyFelix ArltClemens SeidelKarl-Titus HoffmannJürgen MeixensbergerPublished in: Journal of neurological surgery. Part A, Central European neurosurgery (2021)
Time to irradiation had no significant influence on OS of the entire cohort. Nevertheless, a statistically nonsignificant survival prolongation could be observed in patients with residual tumor volume > 2 mL when admitted to radiotherapy within 28 days after surgery.